Imaging Technology

JANUARY 5, 2024

This leading radiopharmaceutical platform provides detailed PET imaging-based diagnosis and dosimetry using long-lived copper-64 ( 64 Cu) for imaging and alpha-particle targeted RPT using lead-212 ( 212 Pb). milla1cf Fri, 01/05/2024 - 11:21 January 5, 2024 — Perspective Therapeutics, Inc.

Radiopharmaceuticals 104

Radiopharmaceuticals Clinic Nuclear Medicine Radiation 104

AuntMinnie

NOVEMBER 20, 2024

Telix Pharmaceuticals is expanding its theranostic pipeline with newly acquired assets targeting fibroblast activation protein (FAP) in nuclear medicine. These were developed by Frank Roesch, PhD, and colleagues at the Institute of Nuclear Chemistry at the Johannes Gutenberg-Universität Mainz, Germany.

Nuclear Medicine 52

Nuclear Medicine Pharmaceutical Radiopharmaceuticals Clinic 52

AuntMinnie

JULY 10, 2024

Centers for Medicare and Medicaid Services (CMS) proposed a new reimbursement plan July 10 for diagnostic PET scans that would provide separate payments for radiopharmaceuticals, as well as an extra payment for hospitals when they use domestically produced technetium-99m (Tc-99m).

Nuclear Medicine 122

Nuclear Medicine Radiopharmaceuticals Imaging Medicare 122

Radiology Business

OCTOBER 7, 2024

Founded in 2019, the firm is focused on developing products for the diagnosis and therapy of blood cancers and other indications not addressed by nuclear medicine.

Nuclear Medicine 96

Nuclear Medicine Radiopharmaceuticals 96

Open Medscience

JANUARY 24, 2024

Thorium-227 emerges in nuclear medicine, revolutionizing cancer treatment through precise, effective radiotheranostic and therapeutic applications. The post The Breakthrough Role of Thorium-227 in Theranostic Radiopharmaceuticals appeared first on Open Medscience.

Radiopharmaceuticals 64

Radiopharmaceuticals Nuclear Medicine 64

Open Medscience

AUGUST 25, 2024

The article explores the theranostic applications of Terbium radionuclides, highlighting their diagnostic and therapeutic potential in nuclear medicine. The post Terbium Radionuclides for Theranostic Applications in Nuclear Medicine appeared first on Open MedScience.

Nuclear Medicine 59

Nuclear Medicine Diagnostic Radiopharmaceuticals 59

AuntMinnie

OCTOBER 14, 2024

The article was published October 10 in the Journal of Nuclear Medicine. These SSTRs can be targeted both with gallium-68 (Ga-68) imaging agents and therapeutic lutetium-177 (Lu-177) radiopharmaceuticals using a so-called theranostics approach. The full article is available here.

Nuclear Medicine 110

Nuclear Medicine Radiopharmaceuticals Insurance Clinic 110

Imaging Technology

JUNE 10, 2024

Anderson , PhD, a trailblazer in nuclear medicine, has been named the 2024 recipient of the Georg Charles de Hevesy Nuclear Pioneer Award. The award was announced by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) during its 2024 Annual Meeting, June 8-11 in Toronto.

Nuclear Medicine 104

Nuclear Medicine Radiopharmaceuticals Disease Imaging 104

Radiology Business

SEPTEMBER 11, 2023

The company has developed a portfolio of nuclear medicine solutions including "lead candidate" MC-339, used for treating small cell lung cancer.

Nuclear Medicine 101

Nuclear Medicine Radiopharmaceuticals 101

AuntMinnie

JULY 12, 2024

As nuclear medicine therapies gain stature compared to nuclear medicine in diagnostic imaging, hospital administrators may be eyeing the potential of adding theranostics services. A shortage of nuclear medicine technologists means a theranostics center may need to limit its patient volume.

Nuclear Medicine 105

Nuclear Medicine Radiation Oncology Radiopharmaceuticals Radiation 105

AuntMinnie

JUNE 3, 2024

With therapeutic radiopharmaceuticals coming to market quickly and available to smaller institutions around the U.S., My vision of a theranostic center includes a flagship facility that has a PET/CT scanner, a SPECT/CT scanner, and then multiple rooms for infusions of radiopharmaceuticals," Siegel explained.

Nuclear Medicine 105

Nuclear Medicine Radiopharmaceuticals Radiation Radiation Oncology 105

AuntMinnie

MARCH 7, 2024

In terms of 2023 spending, the average radiopharmaceutical expenditure per fixed PET site is estimated to be $517,000. In 2023, 38% of PET systems were operated by the PET department, 28% by nuclear medicine, 24% by radiology/imaging, 5% by radiation oncology, and 2% by molecular imaging.

PET Scan 116

PET Scan Nuclear Medicine Radiation Oncology Radiopharmaceuticals 116

AuntMinnie

JULY 8, 2024

Nuclear medicine firm Curium has submitted a new drug application (NDA) for its lutetium-177 (Lu-177) DOTATATE radiopharmaceutical for treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETS).

Nuclear Medicine 97

Nuclear Medicine Radiopharmaceuticals Radiation IT 97

AuntMinnie

MAY 8, 2024

Theranostics treatments are used with increasing frequency now since the approvals and expansions of Lutathera (lutetium-177 [Lu-177]) DOTATATE, a radiopharmaceutical for neuroendrocrine tumors (NETs) and Pluvicto, Lu-177 PSMA-617, for prostate cancer.

Radiopharmaceuticals 75

Radiopharmaceuticals Nuclear Medicine Radiation Hospital 75

Open Medscience

AUGUST 4, 2024

Neuroimaging in nuclear medicine allows for detailed visualisation of brain activity, aiding in diagnosing complex neurological conditions. The post Unlocking the Mysteries of the Brain: Neuroimaging in Nuclear Medicine appeared first on Open MedScience.

Nuclear Medicine 52

Nuclear Medicine Diagnose Radiopharmaceuticals Imaging 52

Open Medscience

JANUARY 12, 2024

Radiopharmaceuticals, combining radioactive and pharmaceutical elements, enable precise diagnosis and treatment in nuclear medicine. The post The Transformative Impact of Radiopharmaceuticals in Medical Imaging appeared first on Open Medscience.

Radiopharmaceuticals 52

Radiopharmaceuticals Medical Imaging Nuclear Medicine Medical 52

Imaging Technology

JUNE 15, 2023

The clinical trial will use this investigational radiopharmaceutical to help understand if patients have CD8+ T cells in their tumors and will, therefore, be more likely to respond to immune checkpoint inhibitors, the main class of immunotherapies currently approved for use.

Radiopharmaceuticals 98

Radiopharmaceuticals Pharmaceutical Nuclear Medicine PET Scan 98

AuntMinnie

JUNE 9, 2024

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has bestowed its Georg Charles de Hevesy Nuclear Pioneer award on Carolyn Anderson, PhD, of the University of Missouri-Columbia (MU). The award honors those who have made outstanding contributions in the field of nuclear medicine, the SNMMI said.

Nuclear Medicine 98

Nuclear Medicine Radiopharmaceuticals Disease Imaging 98

AuntMinnie

JUNE 11, 2024

TORONTO – The radiopharmaceutical Pluvicto improves progression-free survival in patients with metastatic prostate cancer who haven’t undergone taxane therapy, according to research presented at the SNMMI meeting. Oliver Sartor, MD The study, which was awarded SNMMI’s Abstract of the Year award, shared data from the phase III PSMAfore trial.

Nuclear Medicine 122

Nuclear Medicine Radiopharmaceuticals Radiographer Radiographer 122

Open Medscience

AUGUST 10, 2024

The post The Synthesis and Applications of Carbon-11 in Modern Nuclear Medicine appeared first on Open MedScience. Advancements in Carbon-11 synthesis technology have significantly improved the efficiency and accuracy of PET imaging in medical diagnostics.

Nuclear Medicine 52

Nuclear Medicine Diagnostic Medical Imaging 52

Imaging Technology

DECEMBER 12, 2023

milla1cf Tue, 12/12/2023 - 10:00 December 12, 2023 — IBA , a world leader in particle accelerator technology and of radiopharmaceutical production solutions is pleased to announce the start of the installation of a Cyclone 30XP in Poland. Beyond At-211, IBA is also pioneering novel accelerator applications for other theranostic isotopes.

Radiopharmaceuticals 119

Radiopharmaceuticals Nuclear Medicine Clinic IT 119

Future Teleradiology

NOVEMBER 27, 2023

Teleradiology-India Introduction: Nuclear medicine continues to be at the forefront of cutting-edge technologies, pushing the boundaries of diagnostic and therapeutic capabilities. Revolutionary Radioisotopes: Expanding the Diagnostic Toolkit: Explore the latest developments in novel radioisotopes used in nuclear medicine.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Imaging Modalities Radiation 52

Imaging Technology

JULY 9, 2024

I congratulate Marco Campione on this CEO appointment and we look forward to drawing upon his strategic, operational and broad general business expertise as we increase our global leadership throughout the diagnostic radiopharmaceutical industry,” said Fulvio Renoldi Bracco, CEO of Bracco Imaging. Bracco Imaging S.p.A.,

Diagnostic 105

Diagnostic Radiopharmaceuticals Nuclear Medicine Magnetic Resonance Imaging 105

AuntMinnie

JUNE 8, 2023

Radiopharmaceutical manufacturer SpectronRx and nuclear medicine drug distributo.

Radiopharmaceuticals 52

Radiopharmaceuticals Nuclear Medicine Clinic 52

Diagnostic Imaging

JUNE 28, 2023

In a recent interview at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference in Chicago, Phillip Kuo, M.D.,

Radiopharmaceuticals 61

Radiopharmaceuticals Nuclear Medicine Imaging 61

Imaging Technology

FEBRUARY 21, 2024

milla1cf Wed, 02/21/2024 - 18:58 February 21, 2024 — Blue Earth Therapeutics , a Bracco company and emerging leader in the development of innovative next generation therapeutic radiopharmaceuticals, is pleased to share the publication of promising early clinical data with 177Lu-rhPSMA-10.1 177Lu-rhPSMA-10.1

Clinic 104

Clinic Radiopharmaceuticals Nuclear Medicine Hospital 104

UCSF Biomedical Imaging

JUNE 26, 2023

VanBrocklin is a professor in the Department of Radiology and Biomedical Imaging and director of the Radiopharmaceutical Research Program in the Center for Molecular and Functional Imaging at the University of California, San Francisco (UCSF). He is also one of the core faculty for the Master's in Biomedical Imaging (MSBI) program.

Nuclear Medicine 98

Nuclear Medicine Radiopharmaceuticals Imaging Radiology 98

Imaging Technology

JUNE 12, 2024

milla1cf Wed, 06/12/2024 - 21:58 June 12, 2024 — Cathy Sue Cutler, PhD, FSNMMI , chair of the Isotope Research and Production Department at Brookhaven National Laboratory in Upton, New York, has been named as president for the Society of Nuclear Medicine and Molecular Imaging (SNMMI).

Nuclear Medicine 85

Nuclear Medicine Radiopharmaceuticals Education Government 85

Imaging Technology

JUNE 13, 2024

milla1cf Thu, 06/13/2024 - 20:53 June 13, 2024 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) hosted more than 8,000 physicians, technologists, pharmacists, laboratory professionals, scientists and others earlier this week at its 2024 Annual Meeting in Toronto, Ontario. Themed “Innovate. Illuminate.”, Illuminate.”,

Nuclear Medicine 105

Nuclear Medicine Radiopharmaceuticals Education Imaging 105

Future Teleradiology

NOVEMBER 21, 2023

Teleradiology & Radiology data for artificial intelligence (AI) Introduction: Nuclear medicine, a dynamic and rapidly evolving field, continues to break new ground in diagnostic and therapeutic approaches. Introduction to Nuclear Medicine: Merging Physics and Medicine: Provide an overview of nuclear medicine.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiation Teleradiology 52

AuntMinnie

OCTOBER 25, 2024

Louis, MO A first-time Minnies finalist, Dmitry Beyder exemplifies how the role of the nuclear medicine technologist can evolve. Beyder played a key role in launching the radiopharmaceutical therapy (RPT) comprehensive center of excellence at WU, BJH, and Siteman Cancer Center last year. Dmitry Beyder.

Nuclear Medicine 143

Nuclear Medicine Education Radiation Science Radiology Technologist 143

AuntMinnie

APRIL 4, 2024

A decade ago, only a few radiopharmaceutical agents were used to help treat cancer patients. He also helped lead the theranostics conference at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2024 midwinter meeting. However, few freestanding theranostics centers exist today. Hope added.

Nuclear Medicine 88

Nuclear Medicine Radiation Oncology Nursing Radiation 88

Imaging Technology

JUNE 26, 2023

Mahmood was presented the award by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) at its 2023 Annual Meeting. Award recipients will have initiated, developed, and successfully implemented unique and significant transformative value within the field of nuclear medicine and molecular imaging.

Nuclear Medicine 98

Nuclear Medicine Education Radiopharmaceuticals Hospital 98

Open Medscience

MARCH 3, 2024

Therapeutic nuclear medicine leverages radionuclides for targeted cancer treatment, facing challenges in delivery, safety, and regulatory compliance. The post Therapeutic Nuclear Medicine for Advanced Cancer Treatment – Opportunities and Challenges appeared first on Open Medscience.

Nuclear Medicine 40

Nuclear Medicine Radiopharmaceuticals 40

Imaging Technology

JUNE 19, 2023

milla1cf Mon, 06/19/2023 - 19:27 June 19, 2023 — NorthStar Medical Technologies, LLC , a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging, today announced the appointment of Frank Scholz, Ph.D., NorthStar’s commercialized, U.S.-based

Medical 98

Medical Pharmaceutical Radiopharmaceuticals Nuclear Medicine 98

Open Medscience

AUGUST 11, 2024

Adhering to environmental regulations in radiopharmaceutical production ensures safety, reduces waste, and protects the surrounding ecosystem. The post Ensuring Environmental Compliance and Control in Radiopharmaceutical Production appeared first on Open MedScience.

Radiopharmaceuticals 52

Radiopharmaceuticals Patient Safety Nuclear Medicine 52

Imaging Technology

APRIL 13, 2023

He has more than 22 years of operational and commercial expertise in radioisotopes and radiopharmaceuticals. actinium-225 (Ac-225), and drive business development initiatives for NorthStar’s Radiopharmaceutical CDMO/CMO business units. Ac-225 and Cu-67 using environmentally preferable technologies.

Radiopharmaceuticals 97

Radiopharmaceuticals Medical Pharmaceutical Nuclear Medicine 97